ScienceDex / Researcher record
Mark W. Grinstaff
- Boston University · Chemistry (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- R01 Holder
- Early Career
- Mentor
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $5,005,166 | 9 | #1,103 |
| 2025 | $6,146,576 | 11 | #1,009 |
| 2026 | $4,573,212 | 8 | #3,308 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20249 records
- FY202511 records
- FY2026 · selected8 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Citation measures
From OpenAlex data as of September 23, 2026. Google Scholar and Scopus count other sources, so their numbers differ.
Each number opens a page that explains the measure and compares researchers on it.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1858385Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-5453-3668Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- CHEMISTRY
- ENGINEERING (ALL TYPES)
FY2026 award records by amount
NIH award records listing Mark W. Grinstaff as a PI. Multi-PI records show the full award amount for context.
- 5R01CA272637-05R01Co-investigatorSupratherapeutic PTX Buttresses Reduce Locoregional Recurrence Rates Following Surgery for Soft Tissue SarcomasBrigham and Women's Hospital · Surgery (investigator's affiliation)$714.3Kaward amount
- 5R01CA296810-02R01Contact PIModified saRNA Encoded BiTEs for Lung CancerBoston University · Chemistry (NIH department code)$646.8Kaward amount
- 5R01EB038005-02R01Co-investigatorA self-amplifying RNA-based synthetic nanobody platform for next-generation therapeuticsBoston University · Engineering (NIH department code)$638.8Kaward amount
- 5R01DK141923-03R01Contact PILysosomal Regeneration (LysoGen) and Rescue as a Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Boston University · Chemistry (NIH department code)$619.8Kaward amount
- 5R01AR081264-05R01Contact PIThe Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor ModulationBoston University · Chemistry (NIH department code)$609.4Kaward amount
- 5R01AR079489-05R01Contact PISustained Release Relaxin-2 for the Treatment of Frozen ShoulderBoston University · Chemistry (NIH department code)$586.8Kaward amount
- 5R01AR083161-03R01Contact PIA Relaxin-loaded Hydrogel for the Treatment of Hypertrophic ScarsBoston University · Chemistry (NIH department code)$474.4Kaward amount
- 5T32EB006359-17T32Contact PITranslational Research in BiomaterialsBoston University · Chemistry (NIH department code)$282.8Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Mark W. Grinstaff as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardBoston University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1103
- 2024Entered Top 25% NationallyRanked #1103
- 2024Entered Top 10% NationallyRanked #1103
- 2025$10M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Mark W. Grinstaff.